CNE100003RP1
CNE100003RP1
SUZHOU ZELGEN BIOPHARMACEUTICAL
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 27.6B EUR | 30.88B EUR | 26.15B EUR |
Enterprise Value | 25.94B EUR | 29.6B EUR | 24.92B EUR |
Valuation Multiples | |||
Trailing P/E | 50.12x | 58.72x | 53.34x |
Forward P/E | 83.4x | -- | -- |
Price to Sales | 16.82x | 18.94x | 17.46x |
Price to Book | 16.04x | 17.95x | 15.27x |
EV/Revenue | 15.81x | 18.15x | 16.64x |
EV/EBITDA | 52.26x | 52.91x | 48.34x |
Price to FCF (P/FCF) | 144.37x | 48.15x | 40.49x |
EV/FCF | 135.7x | 46.15x | 38.59x |
FCF Yield | 0.69% | 2.08% | 2.47% |